 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Jan. 08, 2023 GLOBE NEWSWIRE Ad hoc announcement pursuant to Art. 53 LR : Molecular Partners AG SIX: MOLN; NASDAQ: MOLN, a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced several developments in its infectious disease and oncology portfolios. These include: ... The post Molecular Partners Provides Updates at 41st Annual JPM Healthcare Conference appeared firs... 